Literature DB >> 11831714

Coronavirus defective-interfering RNA as an expression vector: the generation of a pseudorecombinant mouse hepatitis virus expressing hemagglutinin-esterase.

C L Liao1, X Zhang, M M Lai.   

Abstract

We have developed an expression vector system using a defective-interfering (DI) RNA of mouse hepatitis virus (MHV), a prototype coronavirus, to deliver and express a foreign gene in MHV-infected cells. This vector contains an MHV intergenic sequence to promote the expression of foreign genes. In this study, we used this vector to introduce a hemagglutinin-esterase (HE) protein, an optional MHV structural protein, into the MHV-infected cells. The engineered HE protein could be efficiently incorporated into the virion which did not synthesize its own HE protein, thus generating a pseudorecombinant virus that expresses an exogenous HE protein. The engineered HE protein could be made distinguishable from the native protein by attaching an 8-amino-acid peptide tag at the carboxyl-terminus. Both the engineered and native HE proteins from the HE-producing virus train could be incorporated into the virion, thus generating phenotypically mixed virus particles. We also showed that the HE-expressing DI RNA could be incorporated into viruses, and the engineered HE protein expressed in the infected cells for at least three serial virus passages. Furthermore, we have made two mutants, in which parts of the external domain of the HE protein have been deleted, to study the sequence requirements for the stable expression of HE and its incorporation into MHV virions. Although both of the mutant HE proteins could be expressed in the MHV-infected cells, they failed to be incorporated into virions, suggesting the importance of the extracellular domain of HE protein for its incorporation into virus particles. This vector system enabled the first successful incorporation of a selected coronaviral protein into virions and demonstrates its utility as an expression vector for studying the molecular biology of coronaviruses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 11831714      PMCID: PMC7131598          DOI: 10.1006/viro.1995.1155

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory hemagglutinin esterase protein display reduced fitness in vitro.

Authors:  A Lissenberg; M M Vrolijk; A L W van Vliet; M A Langereis; J D F de Groot-Mijnes; P J M Rottier; R J de Groot
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 2.  Virus maturation by budding.

Authors:  H Garoff; R Hewson; D J Opstelten
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

3.  Protein interactions during coronavirus assembly.

Authors:  V P Nguyen; B G Hogue
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  The spike but not the hemagglutinin/esterase protein of bovine coronavirus is necessary and sufficient for viral infection.

Authors:  Rada Popova; Xuming Zhang
Journal:  Virology       Date:  2002-03-01       Impact factor: 3.616

5.  Assembled coronavirus from complementation of two defective interfering RNAs.

Authors:  K H Kim; K Narayanan; S Makino
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  The nucleocapsid protein of coronavirus mouse hepatitis virus interacts with the cellular heterogeneous nuclear ribonucleoprotein A1 in vitro and in vivo.

Authors:  Y Wang; X Zhang
Journal:  Virology       Date:  1999-12-05       Impact factor: 3.616

7.  In vitro and in ovo expression of chicken gamma interferon by a defective RNA of avian coronavirus infectious bronchitis virus.

Authors:  Karen Hackney; Dave Cavanagh; Pete Kaiser; Paul Britton
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

8.  Polypyrimidine tract-binding protein binds to the complementary strand of the mouse hepatitis virus 3' untranslated region, thereby altering RNA conformation.

Authors:  P Huang; M M Lai
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

9.  Replication and packaging of transmissible gastroenteritis coronavirus-derived synthetic minigenomes.

Authors:  A Izeta; C Smerdou; S Alonso; Z Penzes; A Mendez; J Plana-Durán; L Enjuanes
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Presence of an encephalomyocarditis virus internal ribosome entry site sequence in avian infectious bronchitis virus defective RNAs abolishes rescue by helper virus.

Authors:  Brian Dove; David Cavanagh; Paul Britton
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.